Quiz|Articles|December 3, 2025
Guess the Therapy Answer December 3, 2025
Advertisement
What was the second gene therapy product to be approved by the FDA for transfusion-dependent beta-thalassemia?
Answer: exagamglogene autotemcel (exa-cel; marketed as Casgevy)
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
2
FDA Activity Recap: November 2025 Features SMA Approval, Boxed Warning for Elevidys, and More
3
Lessons Learned From the Past 25 Years of Cell and Gene Therapy Research
4
Key Unknowns Remain in Cell and Gene Therapy
5







































